ADAnna S. Droganova

Anna S. Droganova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna S. Droganova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The role of acyl-ghrelin in the pathogenesis of protein-energy wasting in patients with chronic kidney disease Stage 5D

    by A. A. Yakovenko, Yu. V. Lavrishcheva, A. Sh. Rumyantsev, A. S. Droganova, D. O. Loginova, Ю. В. Лаврищева

    THE AIM OF THE STUDY. To clarify the role of acyl-ghrelin in the development of protein-energy wasting of haemodialysis patients (HD).PATIENTS AND METHODS. A total of 645 patients receiving treatment with programmatic bicarbonate HD for 8.4 ± 5.3 years, including 345 women and 300 men, the average age was 56.8 ± 12.8 years. Nutritional status was assessed using the method proposed by the International Society of Renal Nutrition and Metabolism (ISRNM). For the quantitative determination of acyl-ghrelin, the enzyme-linked immunosorbent assay kit “Active Ghrelin ELISA Kit” (highly sensitive method) from Sceti KK, Japan was used in this work. Reference values: 30 – 62 fmol/ml.RESULTS. The prevalence of protein-energy wasting (PEM) using the ISRNM method was 24.9% (160 patients). Reduced levels of acyl-ghrelin were detected in 352 patients (54.5%). The average acyl-ghrelin values in patients without signs of PEW were 50.2±10.3 fmol/ml, and in patients with PEW 24.9±9.2 fmol/ml (pCONCLUSION. The prevalence of PEW in haemodialysis patients according to the ISRNM method was 24.9%. A reduced level of acyl-ghrelin in the blood serum may be an important pathogenetic link in the development of PEW in haemodialysis patients.

  • Open Access

    Difficulties in Differential Diagnosis of Diseases with Dyspnea: A Mini-Review and a Case Report

    by Anna S. Droganova, I.Y. Lukianova, Tamara P. Bulach, Ivan Yu. Pchelin, Irina Yu. Lukyanova

    Dyspnea is a common and complex symptom that occurs in various physiological and pathological conditions associated with disorders of the respiratory, cardiovascular, or neuromuscular systems. In this article, we discuss the main causes and mechanisms of dyspnea development, types of respiratory failure, and approaches to differential diagnosis. The presented clinical case describes the difficulties in diagnosing and treating a 91‑year-old patient complaining of progressive dyspnea. Despite a history of hypertension and impaired glucose tolerance, initial examinations did not reveal signs of heart failure or a significant heart disease. Chest computed tomography revealed a large hernia of the esophageal opening of the diaphragm with dislocation of abdominal organs into the chest cavity, as well as hyperkyphosis, aggravating restrictive disorders of the lung function. These changes explain the patient’s dyspnea as a consequence of a decrease in the lung volume and mechanical limitation of their mobility.

  • Open Access

    The Association Between Obesity Phenotypes and Cardiovascular Diseases

    by P. Yu. Filiniuk, A. N. Shishkin, I. Yu. Pchelin, V. A. Volovnikova, A. S. Droganova, N. V. Khudyakova

    Cardiovascular diseases and obesity are related medical and social problems. However, some obese people remain free of cardiovascular disease for long periods of time, and the concept of obesity phenotypes that differ in cardiovascular risk has been actively studied. Currently, there are no generally accepted diagnostic criteria for them, and the mechanisms underlying their formation remain unclear. The purpose of this article is to discuss the literature data on obesity phenotypes, their relationship with cardiovascular diseases and mortality, as well as the place of obesity in the domestic algorithm for diagnosing stable coronary heart disease.